查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559906

經導管主動脈瓣置換術(TAVR) 市場報告：2030 年趨勢、預測與競爭分析

Transcatheter Aortic Valve Replacement (TAVR) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

經導管主動脈瓣置換術(TAVR) 趨勢與預測

預計到 2030 年，全球經導管主動脈瓣置換術(TAVR) 市場將達到 198 億美元，2024 年至 2030 年複合年成長率為 16.5%。該市場的主要促進因素是主動脈瓣狹窄病例數量的增加、瓣膜置換術微創手術需求的增加以及 TAVR 設備的持續技術進步。全球經導管主動脈瓣置換術（TAVR）市場未來性廣闊，醫院市場和門診手術中心市場機會龐大。

  • Lucintel 預測，無縫線瓣膜將在預測期內實現高速成長。
  • 預計北美地區在預測期內將出現最高的成長。

經導管主動脈瓣置換術(TAVR) 市場的新興趨勢

TAVR 市場的新興趨勢正在刺激創新方法的發展，以擴大微創心臟瓣膜手術。這反映了不斷進步的技術發展、不斷發展的臨床實踐和不斷變化的患者需求。

  • 改良的閥門設計：新一代 TAVR 閥門採用改良的設計，可提高耐用性、減少旁瓣洩漏並最佳化性能。這些增強功能可以改善患者的治療效果，並將 TAVR 的適用性擴展到更複雜的病例。
  • 微創技術：微創手術正在興起，新的輸送系統和方法不斷發展。這種手術降低了手術風險和恢復時間，並將 TAVR 的使用範圍擴大到了更多的患者群體。
  • 低風險患者：TAVR 越來越不僅適用於高風險患者，也適用於低風險患者。臨床研究報告了更多患者的良好治療結果，刺激了 TAVR 手術的增加。
  • 先進的影像整合：先進的影像技術整合到手術中，例如 3D 超音波心動圖和 CT 成像，進一步完善了 TAVR 手術。增強的診斷影像可以更好地規劃和調整瓣膜尺寸，從而實現更準確的放置和更好的治療結果。
  • 新興市場的成長：由於醫療基礎設施和意識的改善，TAVR 市場在新興市場正在成長。中國、印度等新興國家正迅速採用TAVR技術。這可能是由於這些國家患者的需求不斷增加，並且容易獲得先進的醫療設備。

新興趨勢包括改進的瓣膜設計、微創技術、擴展到低風險患者、先進影像診斷的整合以及新興市場的成長，所有這些都在塑造 TAVR 格局。這些變化正在透過推動創新、改善成果和擴大全球適應範圍來重塑該領域。

經導管主動脈瓣置換術(TAVR) 市場的最新趨勢

近年來，TAVR 市場在技術、監管核准和臨床考慮方面出現了顯著趨勢。這些因素共同提高了 TAVR 手術的有效性、安全性和可近性。

  • 閥門技術的進步：新設計的閥門採用先進材料和卓越的機械特性製造，可減少併發症並提高耐用性。這改善了長期結果並提高了患者滿意度。
  • 新設備核准：最近監管部門核准了新 TAVR 設備，擴大了治療選擇。持續的發展包括使用更薄的瓣膜和改進的輸送系統，進一步擴大 TAVR 手術的適應症，以包括更複雜的解剖候選者。
  • 擴大適應症：TAVR 的適應症正在擴大，包括低風險患者和具有獨特解剖特徵的患者，臨床證據表明這些新群體的結果良好，證據正在累積。
  • 改善臨床結果：使用最新 TAVR 技術的臨床研究表明，臨床結果得到改善，包括更低的併發症發生率和更高的手術成功率。這些改進提高了 TAVR 作為治療選擇的採用率和信心。
  • 全球採用率不斷提高：TAVR 正逐漸在全球範圍內獲得關注，新興市場和其他先前訪問受限的地區的採用率不斷增加。這項進展得益於技術的改進和為改善 TAVR 治療機會所做的努力。

TAVR 的最新進展包括瓣膜技術的進步、監管部門的核准、適應症的擴大、臨床結果的改善以及全球接受度的擴大，所有這些都致力於改善治療前景。這些發展有助於 TAVR 手術在全球範圍內的日益接受和成功。

經導管主動脈瓣置換術(TAVR) 市場的策略性成長機會

TAVR 市場在應用和地區持續出現策略性成長機會。這些都是由不斷的技術進步、臨床進步以及患者對心臟瓣膜微創治療的需求增加所推動的。

  • 新興市場滲透率：隨著醫療保健基礎設施的發展，新興市場具有很高的成長潛力。新興市場中 TAVR 的日益普及將為解決未滿足的需求和市場滲透提供新的機會。
  • 開發下一代設備：投資具有改進功能和性能的下一代 TAVR 設備將為進一步成長鋪平道路。低輪廓閥門和先進輸送系統的持續開發將繼續改善採用率和患者治療效果。
  • 與數位健康解決方案整合：將 TAVR 手術與遠端監控和資料分析等數位健康解決方案相結合，可增強患者管​​理和手術規劃。這不僅改善了臨床結果，而且使業務更有效率。
  • 擴大 TAVR 的適應症：將 TAVR 的適應症擴大到低風險患者和不同的解剖病例也帶來了成長機會。這些新患者群體的積極成果可以擴大市場並提高採用率。
  • 夥伴關係與聯盟：設備製造商、醫療保健提供者和研究機構之間的策略夥伴關係和合作可以加速創新並擴大市場範圍。這些合作夥伴關係預計將加快產品開發並加強臨床實踐。

TAVR市場策略性成長的成長機會包括拓展新興市場、開發下一代設備、融入數位健康解決方案、擴大適應症和策略聯盟。這些可能會刺激市場進一步成長，並進一步促進 TAVR 手術的便利性和高效性。

經導管主動脈瓣置換術(TAVR) 市場促進因素與挑戰

TAVR 市場受到各種促進因素​​和挑戰的主導。主要市場促進因素包括技術進步、監管因素、經濟考量和不斷發展的臨床實踐。識別這些因素對於成功駕馭這個市場並最終實現成長非常重要。

推動經導管主動脈瓣置換術（TAVR）市場的因素包括：

1. 創新：瓣膜設計和輸送系統的創新使 TAVR 成為一個不斷進步的領域。新設備可確保性能並減少併發症，從而改善患者的治療效果。這些被認為是提高採用率並進而帶來市場成長的關鍵點。

2.擴大適應症：擴大TAVR的適應症，包括低風險患者和更複雜的解剖結構，是推動市場需求的關鍵促進因素之一。這些新病患小組的積極臨床結果正在擴大市場和對該手術的接受度。

3. 微創手術的需求不斷成長：微創手術的日益普及正在推動對 TAVR 的需求。由於 TAVR 術後的恢復時間比傳統的心臟直視手術短，因此患者和醫療保健提供者認為 TAVR 是更好的選擇，因為手術風險較低。

4. 監管機構核准：TAVR 設備的新核准和擴大的適應症正在推動市場發展。主要醫療機構的核准增加了先進技術的可用性，並增強了對其使用的信心。

5. 改善醫療基礎設施：醫療基礎設施的開拓正在改善先進技術的獲取，並推動 TAVR 市場的成長，特別是在新興市場。

經導管主動脈瓣置換術(TAVR) 市場面臨的挑戰包括：

1. 手術成本高：手術和設備的高成本阻礙了廣泛採用，特別是在資源匱乏的環境中。為了克服成本挑戰並增加價值，展示更好的治療效果對於市場擴張至關重要。

2. 監管挑戰：必須滿足非常複雜的監管要求才能獲得新器械和適應症的核准。市場進入和創新的驅動力是監管延遲和嚴格要求。

3.報銷政策有限：大多數地區對TAVR治療的報銷政策有限，限制了取得和採用。廣泛的市場接受需要擴大報銷範圍並展示成本效益。

TAVR 的成長將受到技術創新、適應症擴大、對最少介入程序的需求、監管核准和改善的醫療基礎設施的推動。然而，這些都被高昂的手術費用、監管過程中的挑戰以及令人不滿意的報銷政策所抵消。因此，解決這些挑戰是持續成長和廣泛採用的途徑。

按細分市場分類的經導管主動脈瓣置換術(TAVR) 的趨勢

本研究按產品類型、材料、最終用途和地區對全球經導管主動脈瓣置換術(TAVR) 進行預測。

經導管主動脈瓣置換術(TAVR) 市場國家展望

經導管主動脈瓣置換術市場涉及廣泛的技術進步，設備技術的巨大開拓、採用率的不斷提高以及對微創手術的需求不斷成長正在引起人們的興趣。技術創新透過擴大適應症和簡化程序來改善患者的治療結果。美國、中國、德國、印度、日本等世界主要地區在TAVR技術和應用的發展上呈現出全球動能。

  • 美國：在美國，由於瓣膜設計和手術的進步，TAVR 市場正在快速成長。主要進展包括 FDA核准使用新一代瓣膜，該瓣膜擁有更好的輸送系統和低調的設計，以更低的手術風險擴大了患者群體。
  • 中國：由於意識的提高和醫療基礎設施的改善，TAVR 市場正在經歷快速成長。最新進展：隨著微創心臟瓣膜置換術需求的成長，本地開發的 TAVR 設備已獲得中國醫院的核准和採用。
  • 德國：例如德國已經全面採用了目前先進的TAVR技術。最近的改進包括提高設備性能和改善患者相關結果，瓣膜設計和輸送系統的改進可改善臨床結果並減少手術併發症。在印度，其在年輕患者和具有複雜解剖結構的患者中的使用也在擴大。
  • 印度：隨著性能更高的設備和越來越多的人獲得更好的醫療保健，印度的 TAVR 市場正在不斷改善。最近的進展包括過去幾年與國際公司建立的多項開發合作夥伴關係，以推出新版本的 TAVR 技術並擴大該地區嚴重主動脈瓣狹窄患者的治療選擇。
  • 日本：由於新興技術和支持經導管主動脈瓣置換術置換術也出現成長。這包括廣泛使用日本製造的 TAVR 設備以及擴大臨床試驗以評估區域患者群體的長期治療結果和療效。

常問問題

Q.1 經導管主動脈瓣置換術（TAVR）的市場規模有多大？

A1. 到 2030 年，全球經導管主動脈瓣置換術(TAVR) 市場預計將達到 198 億美元。

Q.2 經導管主動脈瓣置換術(TAVR) 市場的成長預測是多少？

A2. 2024年至2030年，全球經導管主動脈瓣置換術（TAVR）市場預計將以16.5%的複合年成長率成長。

Q.3 影響經導管主動脈瓣置換術(TAVR) 市場成長的關鍵促進因素有哪些？

A3. 該市場的主要驅動力是主動脈瓣狹窄病例數量的增加、瓣膜置換術微創手術的需求增加以及 TAVR 設備的持續技術進步。

Q4.市場的主要細分市場是：

A4. 經導管主動脈瓣置換術（TAVR）市場未來性廣闊，醫院市場和門診手術中心市場充滿機會。

Q5.市場的主要企業是：

A5. 經導管主動脈瓣置換術（TAVR）的主要企業是：

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，無縫線瓣膜將在預測期內實現高速成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 預計北美地區在預測期內將出現最高成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球經導管主動脈瓣置換術（TAVR）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球經導管主動脈瓣置換術（TAVR）市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球經導管主動脈瓣置換術(TAVR) 市場
    • 經導管主動脈瓣
    • 無縫線瓣膜
    • 其他
  • 全球經導管主動脈瓣置換術（TAVR）市場（按材質）
    • 不銹鋼
    • 鎳鈦諾
    • 鈷鉻合金
    • 其他
  • 以最終用途分類的經導管主動脈瓣置換術(TAVR) 的全球市場
    • 醫院
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球經導管主動脈瓣置換術（TAVR）市場（按地區）
  • 北美經導管主動脈瓣置換術術 (TAVR) 市場
  • 歐洲經導管主動脈瓣置換術（TAVR）市場
  • 亞太地區置換術(TAVR) 市場
  • 其他地區經導管主動脈瓣置換術（TAVR）市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球經導管主動脈瓣置換術(TAVR) 市場成長機會
    • 全球經導管主動脈瓣置換術(TAVR) 市場按材質的成長機會
    • 全球經導管主動脈瓣置換術(TAVR) 市場成長機會（依最終用途）
    • 全球經導管主動脈瓣置換術(TAVR) 市場成長機會（按地區）
  • 全球經導管主動脈瓣置換術(TAVR) 市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球經導管主動脈瓣置換術(TAVR) 市場容量擴張
    • 全球經導管主動脈瓣置換術(TAVR) 市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences
簡介目錄

Transcatheter Aortic Valve Replacement (TAVR) Trends and Forecast

The future of the global transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets. The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 16.5% from 2024 to 2030. The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuous technological advancements in TAVR devices.

  • Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.
  • North America is expected to witness highest growth over the forecast period.

Emerging Trends in the Transcatheter Aortic Valve Replacement (TAVR) Market

The emerging trends in the TAVR market stimulate innovative approaches toward broadening minimally invasive heart valve procedures. This reflects progressive technology development, evolving clinical practices, and changing patient needs.

  • Improved Valve Designs: New-generation TAVR valves boast of their improved design for better durability, reduced paravalvular leakage, and performance optimization. These enhancements translate to improvements in patient outcomes and extend the applicability of TAVR to more complex cases.
  • Minimally Invasive Techniques: Less-invasive techniques continue to be on the rise, while new delivery systems and approaches continue to be developed. Such techniques reduce procedural risks and recovery times, extending the use of TAVR to a larger patient population.
  • Lower-Risk Patients: TAVR is being indicated for not only high-risk patients but increasingly for those with lower risk, as well. Clinical studies are reporting positive outcomes for the expanded patient group, fueling growth of TAVR procedures.
  • Advanced Imaging Integration: Advanced imaging technologies integrated into the procedure-such as 3D echocardiography and CT imaging-are further refining the art of performing a TAVR. Enhanced imaging aids in yielding better planning and valve sizing, providing greater placement accuracy, and fostering even better procedural outcomes.
  • Growth in Emerging Markets: The TAVR market is growing in emerging markets because of increasing health infrastructures and awareness. In developing countries like China and India, TAVR technology is being adopted very fast. This may be attributed to the ever-rising demand by the patients in these countries and accessibility to medical devices that are advanced.

The emerging trends include improved valve designs, minimally invasive techniques, expansion to lower-risk patients, integration of advanced imaging, and rising growth in emerging markets-all contribute to remodeling the landscape of TAVR. These changes have reshaped this space by driving innovation, improving outcomes, and expanding its indications around the world.

Recent Developments in the Transcatheter Aortic Valve Replacement (TAVR) Market

There are vast developments in technology, regulatory approvals, and clinically related matters in the TAVR market over the recent years. These factors have combined to improve the efficacy, safety, and access of procedures using TAVR.

  • Advances in Valve Technology: Newer designs of valves are being manufactured with advanced materials and better mechanical features that reduce complications and enhance durability. This leads to improved long-term results and increased satisfaction for patients.
  • Regulatory Approval for New Devices: Recent regulatory approvals of newer TAVR devices have expanded treatment options. Ongoing developments include the availability of smaller-profile valves and improved delivery systems that will further expand the candidacy for the TAVR procedure to include more complex anatomic candidates.
  • Indications Expansion: TAVR indications are increasingly being given for patients with low risk and those exhibiting unique anatomical features, with the accumulation of supportive clinical evidence demonstrating favorable outcomes across these newer cohorts.
  • Improved Clinical Outcomes: Clinical studies are demonstrating improved clinical outcomes using the latest TAVR technologies, with lower complication rates and better procedural success. Such improvements are driving up adoptions and confidence in TAVR as a therapeutic option.
  • Increasing Global Adoption: TAVR is gradually gaining momentum globally, with deeper penetration in emerging markets and other geographies where access was earlier limited. This development is thus supported by the technology improvements and efforts being done to increase access to TAVR procedures.

Recent advances in TAVR comprise progress on the fronts of valve technology, regulatory approvals, indication expansion, improvement in clinical outcomes, and greater global acceptance, all acting to improve the landscape for treatment. Such developments are contributing to increased acceptance and success of the TAVR procedures globally.

Strategic Growth Opportunities for Transcatheter Aortic Valve Replacement (TAVR) Market

Growth opportunities in strategic positions continue to emerge in the TAVR market for applications and regions. These are driven by continuous technological advancements, evolving clinical practices, and increasing patient demand for minimally invasive treatments of the heart valves.

  • Emerging Market Penetration: Emerging markets represent a high growth potential as healthcare infrastructure develops. Emerging markets should witness increased availability of TAVR and offer new opportunities for addressing unmet needs and greater market penetration.
  • Development of Next-Generation Devices: Investment in next-generation TAVR devices with enhanced feature and performance capabilities creates further avenues for growth. Ongoing development of smaller profile valves and advanced delivery systems continues to improve adoption and patient outcomes.
  • Integration with Digital Health Solutions: Combining TAVR procedures with digital health solutions-such as remote monitoring and data analytics-will enhance patient management and procedural planning. This allows for not only better clinical outcomes but also operational efficiencies.
  • Expanding Indications for TAVR: Further indications of TAVR into lower-risk patients and a range of anatomical cases also open up opportunities for growth. Positive outcomes from such new patient groups can expand the market and increase adoption.
  • Partnerships and Collaborations: Strategic partnerships and collaborations between device manufacturers, healthcare providers, and research institutions can accelerate innovation and extend the reach of the market. These partnerships may speed up product development and enhance clinical practices.

Growth opportunities in the strategic growth of the TAVR market include expansion into emerging markets, next-generation device development, integration into digital health solutions, expansion of indications, and strategic partnerships. These will probably spur further growth of the market and further facilitate easier access to and higher efficacy of TAVR procedures.

Transcatheter Aortic Valve Replacement (TAVR) Market Driver and Challenges

The TAVR market is governed by various drivers and challenges. Some of the key drivers in the market would include technological advances, regulatory factors, economic considerations, and evolving clinical practices. Discerning these factors becomes important in order to maneuver in this market and eventually achieve growth.

The factors responsible for driving the transcatheter aortic valve replacement (tavr) market include:

1. Innovations in Technology: Technological innovations in valve design and delivery systems are what make TAVR an advancing field. New devices ensure that there is a performance with fewer complications; therefore, better patient outcomes are realized. These are considered points for increasing the adoption rate and, hence, the growth of the market.

2. Expanding Indications: Indication expansion of TAVR to include lower-risk patients and more complex anatomies is one of the major propellers driving market demand. Positive clinical outcomes from these newer patient groups are expanding the market and acceptance of this procedure.

3. Growing Demand for Minimally Invasive Procedures: Growing adoption of minimally invasive procedures fuels the demand for TAVR. Recovery time after TAVR is less compared to conventional open-heart surgery, and hence patients and health providers consider TAVR a better option due to less procedural risk.

4. Regulatory Approvals: New TAVR device approvals and expanded indications are propelling the market. Major health authority approvals improve advanced technology availability and instill confidence in the use of that technology.

5. Healthcare Infrastructure Improvements: The development of healthcare infrastructure is allowing for improved accessibility of advanced technologies and hence promoting the market growth for TAVR, especially in the developing markets.

Challenges in the transcatheter aortic valve replacement (tavr) market are:

1. High Cost of the Procedure: The high cost of the procedure and devices prohibits wide adoption, particularly in resource-poor settings. To overcome the cost-related challenges and value, showing better outcomes are essential for market expansion.

2. Regulatory Challenges: We have to course through very complex regulatory requirements and obtain approvals of both new devices and indications. The drivers of market entry and innovation are regulatory delays and stringent requirements.

3. Limited Reimbursement Policies: In most regions, the limited reimbursement policy for TAVR procedures will provide limited access and adoption. Expanding reimbursement coverage and demonstrating cost-effectiveness are required for wider market acceptance.

The growth of TAVR is propelled by technology innovations, expanding indications, demand for minimal access procedures, regulatory approvals, and improving infrastructure in healthcare. These, in turn, are offset by high procedure costs, woes in the regulatory process, and unsatisfactory reimbursement policies. Thereby, resolving these challenges is the way to continued growth and wider adoption.

List of Transcatheter Aortic Valve Replacement (TAVR) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transcatheter aortic valve replacement (TAVR) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcatheter aortic valve replacement (TAVR) companies profiled in this report include-

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Transcatheter Aortic Valve Replacement (TAVR) by Segment

The study includes a forecast for the global transcatheter aortic valve replacement (TAVR) by product type, material, end use, and region.

Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type [Analysis by Value from 2018 to 2030]:

  • Transcatheter Aortic Valve
  • Sutureless Valve
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Material [Analysis by Value from 2018 to 2030]:

  • Stainless Steel
  • Nitinol
  • Cobalt Chromium
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Transcatheter Aortic Valve Replacement (TAVR) Market

The transcatheter aortic valve replacement market has been a wide technology advancement area in which huge development of device technology, increasing adoption, and growing demand for minimally invasive procedures are driving interest. Innovations improve patient outcomes by expanding indications and improving procedural efficiencies. Various key regions of the world, including the United States, China, Germany, India, and Japan, show global momentum in the development of TAVR technology and applications.

  • United States: In the United States, the TAVR market is rapidly growing due to the advancement in valve designs and procedural techniques. Key developments include the FDA's approvals for the use of newer-generation valves boasting better delivery systems and lower-profile designs to expand the patient population with low surgical risk.
  • China: The increasing awareness and improvement in healthcare infrastructure mean that, very fast growth is seen in the TAVR market. Recent Developments: Locally developed TAVR devices in China reach approval and get adopted by the hospitals amidst the expanding demand for minimally invasive heart valve replacements.
  • Germany: For instance, Germany has fully embraced the current advanced TAVR technology. Recent improvements include enhancing device performance and better patient-related outcomes, with specific refinements in valve design and better delivery systems, translating to better clinical outcomes and reduced procedural complications. The country is also expanding its use in younger patients and those with complex anatomy.
  • India: The TAVR market of India is improving, with growing access to higher devices and better healthcare. Several of the recent development partnerships are with international companies during the last years for the newer versions' introduction of TAVR technologies and expansion of treatment options for patients with severe aortic stenosis in regions.
  • Japan: Japan is also showing growth in the Transcatheter aortic valve replacement market with emerging technologies and supportive clinical evidence for the indication of Transcatheter aortic valve replacement in wider groups of patients. This includes the penetration of Japanese handmade TAVR devices along with expansion of clinical trials for estimating long term and efficacy outcome in local patient sets.

Features of the Global Transcatheter Aortic Valve Replacement (TAVR) Market

Market Size Estimates: Transcatheter aortic valve replacement (TAVR) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transcatheter aortic valve replacement (TAVR) market size by product type, material, end use, and region in terms of value ($B).

Regional Analysis: Transcatheter aortic valve replacement (TAVR) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, materials, end uses, and regions for the transcatheter aortic valve replacement (TAVR) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcatheter aortic valve replacement (TAVR) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the transcatheter aortic valve replacement (TAVR) market size?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030.

Q.2 What is the growth forecast for transcatheter aortic valve replacement (TAVR) market?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to grow with a CAGR of 16.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the transcatheter aortic valve replacement (TAVR) market?

Answer: The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuous technological advancements in TAVR devices.

Q4. What are the major segments for transcatheter aortic valve replacement (TAVR) market?

Answer: The future of the transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets.

Q5. Who are the key transcatheter aortic valve replacement (TAVR) market companies?

Answer: Some of the key transcatheter aortic valve replacement (TAVR) companies are as follows:

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Q6. Which transcatheter aortic valve replacement (TAVR) market segment will be the largest in future?

Answer: Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.

Q7. In transcatheter aortic valve replacement (TAVR) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transcatheter aortic valve replacement (TAVR) market by product type (transcatheter aortic valve, sutureless valve, and others), material (stainless steel, nitinol, cobalt chromium, and others), end use (hospitals, ambulatory surgical centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global Transcatheter Aortic Valve Replacement (TAVR) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 3.3.1: Transcatheter Aortic Valve
    • 3.3.2: Sutureless Valve
    • 3.3.3: Others
  • 3.4: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 3.4.1: Stainless Steel
    • 3.4.2: Nitinol
    • 3.4.3: Cobalt Chromium
    • 3.4.4: Others
  • 3.5: Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgical Centres
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 4.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.2.1: North American Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.2.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.3: European Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.3.1: European Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.3.2: European Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.4: APAC Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.4.1: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.4.2: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.5: ROW Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.5.1: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.5.2: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 6.1.3: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 6.2: Emerging Trends in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: CryoLife
  • 7.2: Abbott
  • 7.3: Micro Interventional Devices
  • 7.4: Boston Scientific
  • 7.5: LivaNova
  • 7.6: Meril Life Sciences
  • 7.7: Edwards Lifesciences